US Patent 11964024 B7H4-targeted antibody-drug conjugates and methods of use thereof
Patent 11964024 was granted and assigned to Mersana Therapeutics on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+31 properties)
Article (+308 characters)
US Patent 11964024 B7H4-targeted antibody-drug conjugates and methods of use thereof
Article
Patent abstract
The present disclosure relates generally to antibody-drug conjugates comprising monoclonal antibodies that specifically bind the human B7-H4 in soluble form, or membrane bound (i.e., when expressed on a cell surface) and to methods of using these conjugates as therapeutics and/or diagnostics.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chen-Ni Chin0
Dorin Toader0
Marc I. Damelin0
Timothy B. Lowinger0
Date of Patent
April 23, 2024
0Patent Application Number
175683760
Date Filed
January 4, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11964024 B7H4-targeted antibody-drug conjugates and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.